Lundbeck’s Serdolect and AstraZeneca’s Seroquel XR To Face Advisory Panel Review
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s Psychopharmacologic Drug Advisory Committee will evaluate the applications for the two antipsychotics in a two day meeting in April.